A Phase 1 Study of SHR-A2102 in Subjects With Advanced Solid Tumors.

Clinical trial NCT05735275 · UNKNOWN

Trial details

NCT number: NCT05735275
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Or Metastatic Solid Tumor Malignancies

Start date: 2023-03-03
Primary completion: 2025-08-31
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.